Awards & Advancement

Mandel-Brehm to join Polaris Partners

Friday, May 12, 2017

Polaris Partners, a venture capital investor in technology and healthcare, announced that Josh Mandel-Brehm will join the firm as an entrepreneur-in-residence. Mandel-Brehm previously held various positions of increasing responsibility at Biogen in both business development and strategy.

[Read More]

Quant HC founder recognized as top woman in MedTech

Thursday, May 11, 2017

Dr. Dana Edelson, the founder and CEO of Quant HC, which develops algorithms for real-time risk stratification of hospitalized patients, was recognized by Becker’s Hospital Review as one of the 110 Women in MedTech to Know for 2017. Dr. Edelson’s company recently launched its flagship analytic, eCART, which enables clinicians to precisely detect inpatients at risk of sepsis, cardiac arrest, and other forms of acute clinical deterioration. eCART currently monitors hundreds of thousands of patients a year, alerting clinicians to those in need of additional resources, and has been shown to decrease cardiac arrests and hospital length of stay.

[Read More]

Agilis Biotherapeutics expands Commercial, Medical Teams

Tuesday, May 9, 2017

Agilis Biotherapeutics, a biotechnology company advancing innovative gene therapy products for the treatment of rare genetic diseases that affect the central nervous system (CNS), has expanded its commercial and medical teams, hiring Markus Peters, Ph.D., as chief commercial officer; Kirsten Gruis, M.D., as chief medical officer; and Anne Marie Conway, M.H.A, R.N., as vice president, Clinical Operations.

[Read More]